Product Description: WNK-IN-11-d3 is an orally active, selective and potent With-No-Lysine (WNK) kinase inhibitor. WNK-IN-11-d3 is effective at regulating cardiovascular homeostasis[1].
Applications: Neuroscience-Neuromodulation
Formula: C21H18D3Cl2N5OS
References: [1]Yamada K, Levell J, Yoon T, et al. Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models. J Med Chem. 2017;60(16):7099-7107.
CAS Number: 2123483-49-6
Molecular Weight: 465.41
Compound Purity: 99.84
Research Area: Cardiovascular Disease
Solubility: DMSO : ≥ 100mg/mL
Target: Ser/Thr Protease